A study revealed that ACPA-IgG exhibits a near 100% frequency of N-glycosylation sites introduced by somatic hypermutation, far exceeding other highly mutated mAbs from RA patients and controls [34]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.